Multimodal AI Predicts Breast Cancer Recurrence from Pathology Slides, Published in Nature Communications
kjgeras · x · 2026-07-06
A research team published a paper in Nature Communications introducing a multimodal AI testing system based on routine breast cancer hematoxylin-eosin (H&E) stained pathology slides. It can predict postoperative recurrence risk across different invasive breast cancer subtypes.
By integrating computational pathology with multimodal AI fusion technology, the system aims to provide a low-cost, convenient prognostic assessment tool for clinical use, reducing the reliance on expensive additional molecular testing. The significance lies in leveraging routine pathology images already available in daily clinical practice to achieve more precise risk stratification.
More from Research
- 3D ResNet Paper Crosses 3,000 Citations Eight Years After CVPR 2018 — HirokatuKataoka · 2026-09-11
- Jeff Heaton's Intro to the Math of Neural Networks eBook Is Free to Download — blaizedsouza · 2026-09-11
- Mathematician Daniel Litt Launches Problem Repo to Track Human vs AI Progress: 15 Problems, 1 Solved — littmath · 2026-09-11
- Open ECDSA.fail challenge uses AI agents to shrink Shor's-algorithm quantum circuits for Bitcoin keys — StefanoGogioso · 2026-09-11
- Alex Townsend posts 200 open problems in numerical linear algebra for humans and AI agents — IgorCarron · 2026-09-11
- Navier-Stokes, Riemann, P vs NP: what this week's math buzzwords mean for you — koltregaskes · 2026-09-11